A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects
NCT02429102 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 135
Last updated 2025-12-22
Summary
The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of MT-8554 in healthy Caucasian subjects.
Conditions
- Healthy
Interventions
- DRUG
-
MT-8554
- DRUG
Sponsors & Collaborators
-
Tanabe Pharma Corporation
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2015-11-30
- Completion
- 2015-11-30
Countries
- United Kingdom
More Related Trials
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB0942 in Healthy Japanese and Caucasian Subjects
NCT03168984 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers
NCT00421226 ·Status: COMPLETED ·Phase: PHASE1
-
Single-Dose Study of MT203
NCT02354599 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males
NCT05396235 ·Status: COMPLETED ·Phase: PHASE1
-
Study of M5049 in Healthy Japanese and Caucasian Participants
NCT04880213 ·Status: COMPLETED ·Phase: PHASE1
-
The Purpose of This Study is to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects.
NCT06994286 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of TT-00920 in Healthy Subjects
NCT05355129 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects
NCT03809039 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)
NCT02923154 ·Status: COMPLETED ·Phase: PHASE2
-
To Assess Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses.
NCT01958645 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human Study to Investigate the Safety, Tolerability and Pharmacokinetics of MAS825 in Healthy Volunteers
NCT04665154 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants
NCT06086886 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Chinese Healthy Adults
NCT05842798 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults
NCT03597217 ·Status: COMPLETED ·Phase: PHASE1
-
MT1013 Clinical TRIAL In Healthy Subject
NCT04783090 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers
NCT02596399 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Participants of Japanese Ethnicity
NCT06084598 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants
NCT05806359 ·Status: COMPLETED ·Phase: PHASE1
-
Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AE58054 in Healthy Japanese and Caucasian Subjects
NCT01975779 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent
NCT05546151 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 in Healthy Japanese Participants
NCT07222254 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dose of TT-00920 in Healthy Subjects
NCT05043792 ·Status: COMPLETED ·Phase: PHASE1
-
AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects
NCT00886756 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability and Pharmacokinetics After Single Dose of AZD2516 to Japanese Healthy Subjects
NCT00972049 ·Status: COMPLETED ·Phase: PHASE1
-
An Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)
NCT02828046 ·Status: COMPLETED ·Phase: PHASE1